Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 1.1.1.205 extracted from

  • O'Gara, M.J.; Lee, C.H.; Weinberg, G.A.; Nott, J.M.; Queener, S.F.
    IMP dehydrogenase from Pneumocystis carinii as a potential drug target (1997), Antimicrob. Agents Chemother., 41, 40-48.
    View publication on PubMedView publication on EuropePMC

Cloned(Commentary)

Cloned (Comment) Organism
-
Pneumocystis carinii

Inhibitors

Inhibitors Comment Organism Structure
Mycophenolic acid 50% inhibition at 0.024 mM Pneumocystis carinii

KM Value [mM]

KM Value [mM] KM Value Maximum [mM] Substrate Comment Organism Structure
0.0217
-
IMP
-
Pneumocystis carinii
0.314
-
NAD+
-
Pneumocystis carinii

Molecular Weight [Da]

Molecular Weight [Da] Molecular Weight Maximum [Da] Comment Organism
50000
-
SDS-PAGE Pneumocystis carinii

Organism

Organism UniProt Comment Textmining
Pneumocystis carinii
-
-
-

Substrates and Products (Substrate)

Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
IMP + NAD+ + H2O
-
Pneumocystis carinii XMP + NADH + H+
-
r